LOL! Four days ago... fossi is wrong again!fossi, "Proph repeatedly praises the cooperation between CZO and Symrise. An agreement that was praised by many parties turned out to be empty chatter in retrospect. In contrast to the hymns of praise, one has the feeling that Symrise has stabbed Ceapro in the back with its own development."
Friday's news release:
"...we are pleased to announce that this customer has resumed ordering from Ceapro during Q1, 2024 with a +20metric ton order of avenanthramides." "Oat beta glucan powder (OBG):
Samples of powder formulation have been successfully prepared and shipped to Symrise AG, Ceapro’s long-term partner, for liquid reformulation and assessment for the Chinese market."